Wendy Luo

Wendy Luo

Auto-generated profile, based on publicly available information

Wendy Luo

Pritzker School of Medicine The University of Chicago Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
EMEleni P. Mimitou
Eleni P. Mimitou
CLCaleb A. Lareau
Caleb A. Lareau
KCKelvin Y. Chen
Kelvin Y. Chen
AZAndre L. Zorzetto-Fernandes
Andre L. Zorzetto-Fernandes
YHYuhan Hao
Yuhan Hao
PSPeter Smibert
Peter Smibert

12 August 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
CLCaleb A. Lareau
Caleb A. Lareau
LLLeif S. Ludwig
Leif S. Ludwig
CMChristoph Muus
Christoph Muus
SGSatyen H. Gohil
Satyen H. Gohil
TZTongtong Zhao
Tongtong Zhao
VSVijay G. Sankaran
Vijay G. Sankaran

3 August 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
FRFlorian V. De Rop
Florian V. De Rop
GHGert Hulselmans
Gert Hulselmans
CFChris Flerin
Chris Flerin
PSPaula Soler-Vila
Paula Soler-Vila
ARAlbert Rafels
Albert Rafels
HHHolger Heyn
Holger Heyn
Single-cell assay for transposase-accessible chromatin by sequencing (scATAC-seq) has emerged as a powerful tool for dissecting regulatory landscapes and cellular heterogeneity. However, an exploration of systemic biases among scATAC-seq technologies has remained absent. In this study, we benchmark the performance of eight scATAC-seq methods across 47 experiments using human peripheral blood mononuclear cells (PBMCs) as a reference sample and develop PUMATAC, a universal preprocessing pipeline, to handle the various sequencing data formats. Our analyses reveal significant differences in sequencing library complexity and tagmentation specificity, which impact cell-type annotation, genotype demultiplexing, peak calling, differential region accessibility and transcription factor motif enrichment. Our findings underscore the importance of sample extraction, method selection, data processing and total cost of experiments, offering valuable guidance for future research. Finally, our data and analysis pipeline encompasses 169,000 PBMC scATAC-seq profiles and a best practices code repository for scATAC-seq data analysis, which are freely available to extend this benchmarking effort to future protocols.

15 April 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LWLara Wahlster
Lara Wahlster
JVJeffrey M. Verboon
Jeffrey M. Verboon
LLLeif S. Ludwig
Leif S. Ludwig
SBSusan C. Black
Susan C. Black
WLWendy Luo
Wendy Luo
VSVijay G. Sankaran
Vijay G. Sankaran
Advances in genome sequencing have resulted in the identification of the causes for numerous rare diseases. However, many cases remain unsolved with standard molecular analyses. We describe a family presenting with a phenotype resembling inherited thrombocytopenia 2 (THC2). THC2 is generally caused by single nucleotide variants that prevent silencing of ANKRD26 expression during hematopoietic differentiation. Short-read whole-exome and genome sequencing approaches were unable to identify a causal variant in this family. Using long-read whole-genome sequencing, a large complex structural variant involving a paired-duplication inversion was identified. Through functional studies, we show that this structural variant results in a pathogenic gain-of-function WAC-ANKRD26 fusion transcript. Our findings illustrate how complex structural variants that may be missed by conventional genome sequencing approaches can cause human disease.

22 January 2018 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
NRNeha S. Raghavan
Neha S. Raghavan
HCHao Chen
Hao Chen
MSMatthew Schipma
Matthew Schipma
WLWendy Luo
Wendy Luo
SCSarah Chung
Sarah Chung
EREva E. Redei
Eva E. Redei
Major depressive disorder (MDD) is a debilitating illness that affects twice as many women than men postpuberty. This female bias is thought to be caused by greater heritability of MDD in women and increased vulnerability induced by female sex hormones. We tested this hypothesis by removing the ovaries from prepubertal Wistar Kyoto (WKY) more immobile (WMI) females, a genetic animal model of depression, and its genetically close control, the WKY less immobile (WLI). In adulthood, prepubertally ovariectomized (PrePubOVX) animals and their Sham-operated controls were tested for depression- and anxiety-like behaviors, using the routinely employed forced swim and open field tests, respectively, and RNA-sequencing was performed on their hippocampal RNA. Our results confirmed that the behavioral and hippocampal expression changes that occur after prepubertal ovariectomy are the consequences of an interaction between genetic predisposition to depressive behavior and ovarian hormone-regulated processes. Lack of ovarian hormones during and after puberty in the WLIs led to increased depression-like behavior. In WMIs, both depression- and anxiety-like behaviors worsened by prepubertal ovariectomy. The unbiased exploration of the hippocampal transcriptome identified sets of differentially expressed genes (DEGs) between the strains and treatment groups. The relatively small number of hippocampal DEGs resulting from the genetic differences between the strains confirmed the genetic relatedness of these strains. Nevertheless, the differences in DEGs between the strains in response to prepubertal ovariectomy identified different molecular processes, including the importance of glucocorticoid receptor-mediated mechanisms, that may be causative of the increased depression-like behavior in the presence or absence of genetic predisposition. This study contributes to the understanding of hormonal maturation-induced changes in affective behaviors and the hippocampal transcriptome as it relates to genetic predisposition to depression.

12 March 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JMJeanie K Meckes
Jeanie K Meckes
PLPatrick H Lim
Patrick H Lim
SWStephanie L Wert
Stephanie L Wert
WLWendy Luo
Wendy Luo
SGStephanie A Gacek
Stephanie A Gacek
EREva E. Redei
Eva E. Redei
Acute stress responsiveness is a quantitative trait that varies in severity from one individual to another; however, the genetic component underlying the individual variation is largely unknown. Fischer 344 (F344) and Wistar Kyoto (WKY) rat strains show large differences in behavioral responsiveness to acute stress, such as freezing behavior in response to footshock during the conditioning phase of contextual fear conditioning (CFC). Quantitative trait loci (QTL) have been identified for behavioral responsiveness to acute stress in the defensive burying (DB) and open field test (OFT) from a reciprocal F2 cross of F344 and WKY rat strains. These included a significant QTL on chromosome 6 (Stresp10). Here, we hypothesized that the Stresp10 region harbors genes with sequence variation(s) that contribute to differences in multiple behavioral response phenotypes between the F344 and WKY rat strains. To test this hypothesis, first we identified differentially expressed genes within the Stresp10 QTL in the hippocampus, amygdala, and frontal cortex of F344 and WKY male rats using genome-wide microarray analyses. Genes with both expression differences and non-synonymous sequence variations in their coding regions were considered candidate quantitative trait genes (QTGs). As a proof-of-concept, the F344.WKY-Stresp10 congenic strain was generated with the Stresp10 WKY donor region into the F344 recipient strain. This congenic strain showed behavioral phenotypes similar to those of WKYs. Expression patterns of Gpatch11 (G-patch domain containing 11), Cdkl4 (Cyclin dependent kinase like 4), and Drc1 (Dynein regulatory complex subunit 1) paralleled that of WKY in the F344.WKY-Stresp10 strain matching the behavioral profiles of WKY as opposed to F344 parental strains. We propose that these genes are candidate QTGs for behavioral responsiveness to acute stress.